Analyst Ratings for Roche (RHHBY)
RHHBY Rating Summary
RHHBY Price Target Summary
- Highest: $55.00 (Argus)
- Lowest: $46.00 (Morgan Stanley)
- Average: $50.50
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$50.50 (+1.5%)
* Over Last 12-Mos
Rating Score: 2.5 / 10
Percentile Rank: 20%
Avg. $ Target:
$50.50 (+1.5%)
* Over Last 12-Mos
Rating Score: 2.5 / 10
Percentile Rank: 20%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/24/2026 | Morgan Stanley | Sarita Kapila | Upgrade | Equalweight (Underweight) |
46.00 (N/A) |
51.20 (49.74) |
-2.85% | Details |
| 4/6/2026 | Argus | Jasper Hellweg | Upgrade | Buy (Hold) |
55.00 (N/A) |
49.85 (49.74) |
-0.22% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
